'Acute Heart Failure': Should We Abandon the Term Altogether?


Journal

Current heart failure reports
ISSN: 1546-9549
Titre abrégé: Curr Heart Fail Rep
Pays: United States
ID NLM: 101196487

Informations de publication

Date de publication:
12 2022
Historique:
accepted: 10 08 2022
pubmed: 28 9 2022
medline: 16 11 2022
entrez: 27 9 2022
Statut: ppublish

Résumé

The distinction between 'acute' and 'chronic' heart failure persists. Our review aims to explore whether reclassifying heart failure decompensation more accurately as an event within the natural history of chronic heart failure has the potential to improve outcomes. Although hospitalisation for worsening heart failure confers a poor prognosis, much of this reflects chronic disease severity. Most patients survive hospitalisation with most deaths occurring in the post-discharge 'vulnerable phase'. Current evidence supports four classes of medications proven to reduce cardiovascular mortality for those who have heart failure with a reduced ejection fraction, with recent trials suggesting worsening heart failure events are opportunities to optimise these therapies. Abandoning the term 'acute heart failure' has the potential to give greater priority to initiating proven pharmacological and device therapies during decompensation episodes, in order to improve outcomes for those who are at the greatest risk.

Identifiants

pubmed: 36166184
doi: 10.1007/s11897-022-00576-9
pii: 10.1007/s11897-022-00576-9
pmc: PMC9513308
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

425-434

Informations de copyright

© 2022. The Author(s).

Références

J Am Coll Cardiol. 2018 Jul 10;72(2):173-182
pubmed: 29976291
JACC Heart Fail. 2017 Sep;5(9):652-659
pubmed: 28859754
BMJ Open. 2021 Jun 16;11(6):e046160
pubmed: 34135043
N Engl J Med. 2011 Mar 3;364(9):797-805
pubmed: 21366472
JAMA. 2020 Nov 17;324(19):1948-1956
pubmed: 33201202
N Engl J Med. 2005 Jan 20;352(3):225-37
pubmed: 15659722
N Engl J Med. 2022 Sep 29;387(13):1185-1195
pubmed: 36027559
Lancet. 2020 Jul 11;396(10244):121-128
pubmed: 32446323
Circulation. 2006 Mar 21;113(11):1424-33
pubmed: 16534009
JACC Heart Fail. 2020 Nov;8(11):943-953
pubmed: 32800512
Eur J Heart Fail. 2019 Nov;21(11):1415-1422
pubmed: 31074184
N Engl J Med. 2019 Aug 22;381(8):716-726
pubmed: 31433919
ESC Heart Fail. 2019 Aug;6(4):774-783
pubmed: 31218850
J Am Coll Cardiol. 2010 Apr 27;55(17):1803-10
pubmed: 20413029
Catheter Cardiovasc Interv. 2021 Sep;98(3):607-612
pubmed: 33817969
Eur J Heart Fail. 2018 Feb;20(2):332-341
pubmed: 28990358
JAMA. 2019 Dec 17;322(23):2292-2302
pubmed: 31846016
Lancet. 2019 Jan 5;393(10166):61-73
pubmed: 30429050
Echo Res Pract. 2017 Mar;4(1):R15-R20
pubmed: 28196811
N Engl J Med. 2019 Feb 7;380(6):539-548
pubmed: 30415601
Eur Heart J. 2022 Jun 14;43(23):2224-2234
pubmed: 35393622
N Engl J Med. 2018 Sep 27;379(13):1205-1215
pubmed: 30280654
Eur J Heart Fail. 2020 Mar;22(3):543-553
pubmed: 31908129
Open Heart. 2021 Mar;8(1):
pubmed: 33653703
Am Heart J. 2005 Dec;150(6):1239
pubmed: 16338265
Eur Heart J. 2016 Jul 14;37(27):2129-2200
pubmed: 27206819
N Engl J Med. 2018 Dec 13;379(24):2297-2306
pubmed: 30145927
Heart. 2011 Oct;97(20):1675-80
pubmed: 21807656
N Engl J Med. 2020 Oct 8;383(15):1413-1424
pubmed: 32865377
N Engl J Med. 2018 Dec 13;379(24):2307-2318
pubmed: 30280640
Lancet. 2021 Sep 11;398(10304):991-1001
pubmed: 34461042
Circulation. 2020 Feb 4;141(5):352-361
pubmed: 31736342
BMJ Support Palliat Care. 2021 Aug 17;:
pubmed: 34404746
Nat Med. 2022 Mar;28(3):568-574
pubmed: 35228754
Eur J Heart Fail. 2019 Feb;21(2):227-234
pubmed: 30548129
Circ Heart Fail. 2021 Apr;14(4):e007871
pubmed: 33775110
Health Qual Life Outcomes. 2020 Aug 3;18(1):262
pubmed: 32746842
Eur Heart J. 2011 Sep;32(18):2266-73
pubmed: 21362703
Eur J Heart Fail. 2019 Aug;21(8):998-1007
pubmed: 31134724
Nat Rev Cardiol. 2015 Apr;12(4):220-9
pubmed: 25666406
Lancet. 2021 Sep 11;398(10304):935-936
pubmed: 34461039
JACC Cardiovasc Imaging. 2019 Feb;12(2):353-362
pubmed: 30553663
N Engl J Med. 2008 Jul 10;359(2):142-51
pubmed: 18614781
Lancet. 2013 Jan 5;381(9860):29-39
pubmed: 23141816
J Am Coll Cardiol. 2019 May 21;73(19):2365-2383
pubmed: 30844480
Circulation. 2011 Oct 18;124(16):1719-26
pubmed: 21931078
N Engl J Med. 2021 Jan 14;384(2):117-128
pubmed: 33200892
N Engl J Med. 2021 Oct 14;385(16):1451-1461
pubmed: 34449189
Eur Heart J. 2021 Sep 21;42(36):3599-3726
pubmed: 34447992
N Engl J Med. 2005 Apr 14;352(15):1539-49
pubmed: 15753115
J Cardiovasc Med (Hagerstown). 2021 Nov 1;22(11):848-856
pubmed: 34261079
N Engl J Med. 2019 Nov 21;381(21):1995-2008
pubmed: 31535829
Eur Heart J. 2006 Dec;27(23):2823-32
pubmed: 17074775
Eur Heart J. 2013 Mar;34(11):835-43
pubmed: 23293303
ESC Heart Fail. 2020 Dec;7(6):3281-3284
pubmed: 33016650
N Engl J Med. 2010 Mar 4;362(9):779-89
pubmed: 20200382
N Engl J Med. 2014 Sep 11;371(11):993-1004
pubmed: 25176015
BMC Public Health. 2020 Jan 10;20(1):36
pubmed: 31924185
Eur Heart J. 2022 Feb 12;43(7):561-632
pubmed: 34453165
Crit Care. 2019 Nov 29;23(1):385
pubmed: 31783891
Eur J Heart Fail. 2020 Dec;22(12):2327-2339
pubmed: 32892431
J Am Coll Cardiol. 2003 May 21;41(10):1797-804
pubmed: 12767667
N Engl J Med. 2017 May 18;376(20):1956-1964
pubmed: 28402745
JAMA. 2007 May 2;297(17):1883-91
pubmed: 17473298
Eur Heart J. 2017 Aug 07;38(30):2352-2360
pubmed: 28575235
Eur J Heart Fail. 2022 Jan;24(1):227-229
pubmed: 34779112

Auteurs

Sam Straw (S)

Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK. s.straw@leeds.ac.uk.

Andreas Napp (A)

Department of Internal Medicine I, University Clinic, RWTH Aachen University, Aachen, Germany.

Klaus K Witte (KK)

Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK.
Department of Internal Medicine I, University Clinic, RWTH Aachen University, Aachen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH